XML 69 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
Capital Stock
12 Months Ended
Dec. 31, 2018
Equity [Abstract]  
CAPITAL STOCK
CAPITAL STOCK
At December 31, 2018, there were 300,000,000 shares of common stock and 30,000,000 shares of serial preferred stock authorized for issuance. Of the authorized serial preferred stock, 3,000,000 shares are designated as cumulative redeemable serial preferred and 1,000,000 shares are designated as convertible serial preferred stock. See Note 12. Under the 2006 Equity and Performance Incentive Plan (2006 Employee Plan), 23,700,000 shares may be issued or transferred. See Note 13. An aggregate of 9,643,433, 10,715,939 and 7,720,815 shares of common stock at December 31, 2018, 2017 and 2016, respectively, were reserved for the exercise and future grants of option rights and future grants of restricted stock and restricted stock units. See Note 13. Shares outstanding shown in the following table included 489,647, 489,260 and 488,714 shares of common stock held in a revocable trust at December 31, 2018, 2017 and 2016, respectively. The revocable trust is used to accumulate assets for the purpose of funding the ultimate obligation of certain non-qualified benefit plans. Transactions between the Company and the trust are accounted for in accordance with the Deferred Compensation – Rabbi Trusts Subtopic of the Compensation Topic of the ASC, which requires the assets held by the trust be consolidated with the Company’s accounts.
 
 
Shares
in Treasury
 
Shares
Outstanding
Balance at January 1, 2016
23,514,054

 
92,246,525

Shares tendered as payment for option rights exercised
3,441

 
(3,441
)
Shares issued for exercise of option rights
 
 
733,876

Shares tendered in connection with grants of restricted stock
59,916

 
(59,916
)
Net shares issued for grants of restricted stock
 
 
95,987

Balance at December 31, 2016
23,577,411

 
93,013,031

Shares tendered as payment for option rights exercised
16,545

 
(16,545
)
Shares issued for exercise of option rights
 
 
1,152,015

Shares tendered in connection with grants of restricted stock
82,777

 
(82,777
)
Net shares canceled of restricted stock
 
 
(182,079
)
Balance at December 31, 2017
23,676,733

 
93,883,645

Shares tendered as payment for option rights exercised
1,159

 
(1,159
)
Shares issued for exercise of option rights
 
 
661,599

Shares tendered in connection with grants of restricted stock
52,144

 
(52,144
)
Net shares issued for grants of restricted stock
 
 
149,821

Treasury stock purchased
1,525,000

 
(1,525,000
)
Balance at December 31, 2018
25,255,036

 
93,116,762